Welcome to the ACCLAIM Study for people with relapse-remitting MS
The ACCLAIM Study is a clinical trial to test whether abatacept can stop or delay the progression of relapsing-remitting MS. The science behind abatacept is different from other approved treatments for MS.
Am I Eligible?
Find out if you qualify for this trial.
Find the ACCLAIM clinical research centers near you.